In addition, adiponectin levels are reduced (Bluher 2014; Kaur 2014), resulting in an increased leptin/adiponectin ratio, which serves as a robust biomarker for the metabolic syndrome (Falahi et al. 2013; Satoh et al. 2004). This evidence concerns the gene ADIPOQ and metabolic syndrome.